Hilary Dietz

Center for Cancer Immunotherapy, Duke University School of Medicine, Durham, NC, USA, United States

Regeneron Pharmaceuticals, Inc (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)

Presentation(s):

• Real-World Treatment Patterns Before and After Receiving PD-L1 Test Results in Patients with Advanced Non-small Cell Lung Cancer (aNSCLC)

  Sunday, August 28, 2022
  2:15 PM – 2:30 PM CEST